loading...| Preferred Name |
Tazobactam |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62079 |
| CAS_Registry |
89786-04-9 |
| Chemical_Formula |
C10H12N4O5S |
| code |
C62079 |
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977 |
| Contributing_Source |
CTRP FDA |
| DEFINITION |
A penicillanic acid sulfone derivative and beta-lactamase inhibitor with antibacterial activity. Tazobactam contains a beta-lactam ring and irreversibly binds to beta-lactamase at or near its active site. This protects other beta-lactam antibiotics from beta-lactamase catalysis. This drug is used in conjunction with beta-lactamase susceptible penicillins to treat infections caused by beta-lactamase producing organisms. |
| Display_Name |
Tazobactam |
| FDA_UNII_Code |
SE10G96M8W |
| FULL_SYN |
YTR-830H TAZOBACTAM (2S,3S,5R)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 4,4-dioxide Tazobactam |
| Has_Salt_Form | |
| label |
Tazobactam |
| Legacy Concept Name |
Tazobactam_Base |
| Preferred_Name |
Tazobactam |
| prefixIRI |
Thesaurus:C62079 |
| prefLabel |
Tazobactam |
| Semantic_Type |
Pharmacologic Substance Organic Chemical Antibiotic |
| UMLS_CUI |
C0075870 |
| subClassOf |